| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |